Stock Events

Stock Events

Neoleukin Therapeutics (NLTX) Q1 2023 Earnings

8MayConfirmed

Aug 22

Nov 22

Q4 2022

Q1 2023

-0.3

-0.24

-0.18

-0.12

Details

Expected EPS

-0.12

Actual EPS

-0.2

Surprise EPS

-0.08

Surprise Percent

+66.67%

Description

Neoleukin Therapeutics (NLTX) has reported earnings of -0.2 per share for Q1 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.